Inspire Medical Systems (NASDAQ:INSP) CEO Timothy P. Herbert sold 15,000 shares of the stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $56.47, for a total transaction of $847,050.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Shares of NASDAQ:INSP traded up $0.85 during mid-day trading on Thursday, hitting $56.82. The stock had a trading volume of 404,702 shares, compared to its average volume of 367,729. Inspire Medical Systems has a 12-month low of $22.50 and a 12-month high of $64.34.
Inspire Medical Systems (NASDAQ:INSP) last issued its quarterly earnings results on Tuesday, February 26th. The company reported ($0.22) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.32) by $0.10. The firm had revenue of $16.56 million during the quarter, compared to analysts’ expectations of $15.42 million. The business’s revenue was up 66.3% on a year-over-year basis.
Several analysts recently commented on the stock. Berenberg Bank assumed coverage on shares of Inspire Medical Systems in a research note on Wednesday, November 28th. They set a “sell” rating and a $31.00 target price for the company. Dougherty & Co assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, February 5th. They set a “buy” rating and a $64.00 target price for the company. Finally, Zacks Investment Research lowered shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $44.11.
Large investors have recently modified their holdings of the stock. Capital Financial Planning LLC purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $27,000. Arcadia Investment Management Corp MI purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $40,000. Great West Life Assurance Co. Can purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $50,000. Legal & General Group Plc lifted its position in shares of Inspire Medical Systems by 57.7% in the 4th quarter. Legal & General Group Plc now owns 1,843 shares of the company’s stock valued at $78,000 after acquiring an additional 674 shares in the last quarter. Finally, Cutler Group LP purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $92,000.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Featured Article: Dividend Aristocrat Index
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.